Porous Oral Drug Delivery System: Tablets

被引:0
|
作者
Shikha Y. Singh
Ruchi Verma
Lalit Kumar
机构
[1] Manipal Academy of Higher Education,Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences
[2] Manipal Academy of Higher Education,Department of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences
来源
关键词
porous matrices; porous compacts; dissolution rate; solubility enhancement; bioavailability enhancement; 1. Introduction;
D O I
暂无
中图分类号
学科分类号
摘要
One of the most active and promising areas of research in this pharmaceutical field is the application of porous structures in solid-state pharmaceuticals, particularly given the large number of existing and emerging therapeutic molecules that are classified as poorly soluble, including approximately 40% of the top 200 oral drugs globally. Porous compacts have been extensively studied for pharmaceutical applications due to their good biocompatibility, biodegradability, and satisfactory solubility at low toxicity. Porous compacts can be filled in hard gelatine capsule shells or processed to form tablets. Porous formulations in the tablet form showed good biocompatibility without causing undesirable side effects in biological systems. The porous particulate drug formulations can be of both types such as immediate or sustained release delivery system. The evolution of porous matrices as potential drug delivery systems continues with ongoing efforts in improving the loading and controlled release of therapeutics, with particular interest in targeted delivery. The mechanism of immediate release from porous tablets can be attributed to quick entry of water into porous matrix which causes rapid disintegration and dissolution of the tablet. The oral bioavailability of poorly water-soluble drugs is enhanced by porous compacts. Porous compacts are also used to enhance the dissolution of relatively insoluble drugs.
引用
收藏
页码:553 / 561
页数:8
相关论文
共 50 条
  • [1] Porous Oral Drug Delivery System: Tablets
    Singh, Shikha Y.
    Verma, Ruchi
    Kumar, Lalit
    PHARMACEUTICAL CHEMISTRY JOURNAL, 2018, 52 (06) : 553 - 561
  • [2] Mini-tablets: a contemporary system for oral drug delivery in targeted patient groups
    Aleksovski, Aleksandar
    Dreu, Rok
    Gasperlin, Mirjana
    Planinsek, Odon
    EXPERT OPINION ON DRUG DELIVERY, 2015, 12 (01) : 65 - 84
  • [3] IMMEDIATE RELEASE DRUG DELIVERY SYSTEM (TABLETS)
    Rishikesh
    Bhuyian, Mohiuddin Ahmed
    Dewan, Irin
    Ghosh, Drishti Rani
    Islam, Md. Asraful
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2013, 4 (01): : 124 - 131
  • [4] ORAL SUSTAINED-RELEASE DRUG DELIVERY - PELLETS OR TABLETS
    SAM, T
    RUBINSTEIN, MH
    PHARMACY INTERNATIONAL, 1985, 6 (11): : 265 - 266
  • [5] Fast disintegrating tablets: Opportunity in drug delivery system
    Parkash, Ved
    Maan, Saurabh
    Deepikal
    Yadav, Shiv Kumar
    Hemlata
    Jogpal, Vikas
    JOURNAL OF ADVANCED PHARMACEUTICAL TECHNOLOGY & RESEARCH, 2011, 2 (04) : 223 - 235
  • [6] Porous pellets as drug delivery system
    Cosijns, A.
    Nizet, D.
    Nikolakakis, I.
    Vervaet, C.
    De Beer, T.
    Siepmann, F.
    Siepmann, J.
    Evrard, B.
    Remon, J. P.
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2009, 35 (06) : 655 - 662
  • [7] Bilayer tablets: A developing novel drug delivery system
    Akhtar, Muneeba
    Jamshaid, Muhammad
    Zaman, Muhammad
    Mirza, Agha Zeeshan
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2020, 60
  • [8] The Role of Oral Controlled Release Matrix Tablets in Drug Delivery Systems
    Nokhodchi, Ali
    Raja, Shaista
    Patel, Pryia
    Asare-Addo, Kofi
    BIOIMPACTS, 2012, 2 (04) : 175 - 187
  • [9] Unique oral drug delivery system
    Ottenbrite, RM
    Zhao, RF
    Milstein, S
    CHINESE JOURNAL OF POLYMER SCIENCE, 1995, 13 (04) : 315 - 321
  • [10] Zaleplon microparticles delivery in patient centric drug delivery systems (oral disintegrating tablets and oral dissolving film)
    Popescu, Carmen
    Manda, Prashanth
    Juluri, Abhishek
    Repka, Michael A.
    Murthy, Narasimha S.
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2018, 44 (05) : 871 - 871